Sun Pharmaceutical Industries is one of India’s largest pharmaceutical companies, engaged in the manufacturing and marketing of a wide range of pharmaceutical formulations and active pharmaceutical ingredients. The company’s focus on research and development, coupled with strategic acquisitions, has expanded its global footprint. As of February 2025, Sun Pharma’s market capitalization stands at around ₹3.93 lakh crore. Its commitment to innovation and expanding its product portfolio positions it well in the growing pharmaceutical sector.
Investing in these ten companies offers exposure to diverse sectors of the Indian economy, each with strong fundamentals and growth prospects. While these stocks present promising opportunities for long-term growth, potential investors should conduct thorough research and consider their individual risk tolerance before making investment decisions.
